Loading...
Programmed Death Ligand 1; An Immunotarget for Renal Cell Carcinoma
BACKGROUND: In this era of developing targeted therapies and immunotherapies as a treatment for renal cell carcinoma (RCC), Programmed death ligand 1 (PDL1) as a novel biomarker for RCC is analysed in our study. About 90% of all renal cancers are Renal Cell Carcinoma. Most cases are diagnosed incide...
Na minha lista:
| Udgivet i: | Asian Pac J Cancer Prev |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
West Asia Organization for Cancer Prevention
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6982669/ https://ncbi.nlm.nih.gov/pubmed/31653140 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31557/APJCP.2019.20.10.2951 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|